Treatment options for alopecia: An update, looking to the future

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Introduction: Hair loss is a very common complaint. The diagnosis is based on clinical, dermoscopic and pathological examination. The treatment is usually continuous and requires strong compliance. Areas covered: This article aims to i) summarize current treatment options for the most common forms of hair loss; ii) update the literature on treatment options to emerge over the 3 years since the release of the first edition of this article in 2009 [1] Tosti A, Duque-Estrada B. Treatment strategies for alopecia. Expert Opin Pharmacother 2009;10(6):1017-1026.; and iii) outline future strategies for treating alopecia. Expert opinion: There is good evidence-based information for the treatment of androgenetic alopecia. There are very few good-quality randomized studies, and no information about long-term results for most of the available treatments for alopecia areata and cicatricial alopecias. Significant research success has been achieved over the past few years through i) discovering the genetic profile of alopecia areata; ii) working on follicular neogenesis in androgenetic alopecia; and iii) discovering the PPAR-γ pathway in scarring alopecia.

Original languageEnglish
Pages (from-to)1271-1281
Number of pages11
JournalExpert Opinion on Pharmacotherapy
Volume13
Issue number9
DOIs
StatePublished - Jun 1 2012

Fingerprint

Alopecia
Alopecia Areata
Peroxisome Proliferator-Activated Receptors
Expert Testimony
Compliance
Cicatrix
Research

Keywords

  • Alopecia areata
  • Androgenetic alopecia
  • Cicatricial alopecia
  • Clobetasol
  • Corticosteroids
  • Discoid lupus erythematosus
  • Dutasteride
  • Finasteride
  • Folliculitis decalvans
  • Hair loss
  • Hydroxychloroquine
  • Isotretinoin
  • Lichen planopilaris
  • Minoxidil
  • Pioglitazone
  • PRP
  • Scalp
  • Topical immunotherapy
  • Treatment

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology

Cite this

Treatment options for alopecia : An update, looking to the future. / Miteva, Mariya; Tosti, Antonella.

In: Expert Opinion on Pharmacotherapy, Vol. 13, No. 9, 01.06.2012, p. 1271-1281.

Research output: Contribution to journalArticle

@article{04c5fa50b71440328e28f3a4ad7a92da,
title = "Treatment options for alopecia: An update, looking to the future",
abstract = "Introduction: Hair loss is a very common complaint. The diagnosis is based on clinical, dermoscopic and pathological examination. The treatment is usually continuous and requires strong compliance. Areas covered: This article aims to i) summarize current treatment options for the most common forms of hair loss; ii) update the literature on treatment options to emerge over the 3 years since the release of the first edition of this article in 2009 [1] Tosti A, Duque-Estrada B. Treatment strategies for alopecia. Expert Opin Pharmacother 2009;10(6):1017-1026.; and iii) outline future strategies for treating alopecia. Expert opinion: There is good evidence-based information for the treatment of androgenetic alopecia. There are very few good-quality randomized studies, and no information about long-term results for most of the available treatments for alopecia areata and cicatricial alopecias. Significant research success has been achieved over the past few years through i) discovering the genetic profile of alopecia areata; ii) working on follicular neogenesis in androgenetic alopecia; and iii) discovering the PPAR-γ pathway in scarring alopecia.",
keywords = "Alopecia areata, Androgenetic alopecia, Cicatricial alopecia, Clobetasol, Corticosteroids, Discoid lupus erythematosus, Dutasteride, Finasteride, Folliculitis decalvans, Hair loss, Hydroxychloroquine, Isotretinoin, Lichen planopilaris, Minoxidil, Pioglitazone, PRP, Scalp, Topical immunotherapy, Treatment",
author = "Mariya Miteva and Antonella Tosti",
year = "2012",
month = "6",
day = "1",
doi = "10.1517/14656566.2012.685160",
language = "English",
volume = "13",
pages = "1271--1281",
journal = "Expert Opinion on Pharmacotherapy",
issn = "1465-6566",
publisher = "Informa Healthcare",
number = "9",

}

TY - JOUR

T1 - Treatment options for alopecia

T2 - An update, looking to the future

AU - Miteva, Mariya

AU - Tosti, Antonella

PY - 2012/6/1

Y1 - 2012/6/1

N2 - Introduction: Hair loss is a very common complaint. The diagnosis is based on clinical, dermoscopic and pathological examination. The treatment is usually continuous and requires strong compliance. Areas covered: This article aims to i) summarize current treatment options for the most common forms of hair loss; ii) update the literature on treatment options to emerge over the 3 years since the release of the first edition of this article in 2009 [1] Tosti A, Duque-Estrada B. Treatment strategies for alopecia. Expert Opin Pharmacother 2009;10(6):1017-1026.; and iii) outline future strategies for treating alopecia. Expert opinion: There is good evidence-based information for the treatment of androgenetic alopecia. There are very few good-quality randomized studies, and no information about long-term results for most of the available treatments for alopecia areata and cicatricial alopecias. Significant research success has been achieved over the past few years through i) discovering the genetic profile of alopecia areata; ii) working on follicular neogenesis in androgenetic alopecia; and iii) discovering the PPAR-γ pathway in scarring alopecia.

AB - Introduction: Hair loss is a very common complaint. The diagnosis is based on clinical, dermoscopic and pathological examination. The treatment is usually continuous and requires strong compliance. Areas covered: This article aims to i) summarize current treatment options for the most common forms of hair loss; ii) update the literature on treatment options to emerge over the 3 years since the release of the first edition of this article in 2009 [1] Tosti A, Duque-Estrada B. Treatment strategies for alopecia. Expert Opin Pharmacother 2009;10(6):1017-1026.; and iii) outline future strategies for treating alopecia. Expert opinion: There is good evidence-based information for the treatment of androgenetic alopecia. There are very few good-quality randomized studies, and no information about long-term results for most of the available treatments for alopecia areata and cicatricial alopecias. Significant research success has been achieved over the past few years through i) discovering the genetic profile of alopecia areata; ii) working on follicular neogenesis in androgenetic alopecia; and iii) discovering the PPAR-γ pathway in scarring alopecia.

KW - Alopecia areata

KW - Androgenetic alopecia

KW - Cicatricial alopecia

KW - Clobetasol

KW - Corticosteroids

KW - Discoid lupus erythematosus

KW - Dutasteride

KW - Finasteride

KW - Folliculitis decalvans

KW - Hair loss

KW - Hydroxychloroquine

KW - Isotretinoin

KW - Lichen planopilaris

KW - Minoxidil

KW - Pioglitazone

KW - PRP

KW - Scalp

KW - Topical immunotherapy

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84861366665&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861366665&partnerID=8YFLogxK

U2 - 10.1517/14656566.2012.685160

DO - 10.1517/14656566.2012.685160

M3 - Article

C2 - 22594679

AN - SCOPUS:84861366665

VL - 13

SP - 1271

EP - 1281

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

SN - 1465-6566

IS - 9

ER -